Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of cysteine metabolic process. [GOC:TermGenie]
The regulation of cysteine metabolic process is a complex and multifaceted process that ensures proper levels of cysteine, a crucial amino acid, are maintained within cells and organisms. It involves a delicate interplay of various factors, including:
1. **Gene Expression Regulation:**
- Transcription factors like Nrf2 and ATF4 play a critical role in regulating the expression of genes involved in cysteine biosynthesis, uptake, and degradation. They respond to cellular stress signals, such as oxidative stress and amino acid deprivation, activating genes like the cystathionine beta-synthase (CBS) gene for cysteine synthesis.
2. **Enzyme Activity Regulation:**
- Enzymes involved in cysteine metabolism, such as cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CSE), are subject to both allosteric and covalent modifications.
- CBS activity is regulated by S-adenosylmethionine (SAM) and cystathionine, acting as allosteric activators, while hydrogen sulfide (H2S) acts as an inhibitor.
- CSE activity can be regulated by phosphorylation and S-nitrosylation.
3. **Transport Regulation:**
- Cysteine uptake and efflux across cell membranes are tightly controlled by specific transporters.
- Systems like the xCT transporter, a cystine/glutamate antiporter, mediate cysteine uptake, while other transporters contribute to its efflux.
4. **Feedback Inhibition:**
- Cysteine itself can act as a feedback inhibitor, regulating its own metabolism.
- High cysteine levels can suppress the activity of enzymes like CBS, reducing cysteine synthesis.
5. **Nutrient Availability:**
- The availability of other nutrients, such as methionine and serine, influences cysteine metabolism.
- Methionine serves as a precursor for cysteine biosynthesis, and serine is required for the transsulfuration pathway.
6. **Redox Status:**
- Cysteine plays a critical role in maintaining cellular redox balance.
- The cellular redox state can influence cysteine metabolism by affecting the activity of enzymes and transporters involved in its regulation.
7. **Cellular Signaling:**
- Cysteine and its derivatives, like glutathione, participate in redox signaling pathways.
- These signaling events can influence gene expression and other cellular processes, indirectly affecting cysteine metabolism.
8. **Hormonal Regulation:**
- Hormones such as insulin and growth hormone can influence cysteine metabolism by affecting gene expression and enzyme activity.
The intricate regulation of cysteine metabolism ensures that adequate levels of this essential amino acid are available for various cellular functions, including protein synthesis, redox homeostasis, and detoxification. Dysregulation of cysteine metabolism can lead to various pathological conditions, highlighting the importance of this process for overall health.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cystine/glutamate transporter | A cystine/glutamate transporter that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UPY5] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
mesalamine | mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position. Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed) | amino acid; aromatic amine; monocarboxylic acid; monohydroxybenzoic acid; phenols | non-steroidal anti-inflammatory drug |
sulfapyridine | sulfapyridine : A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position. Sulfapyridine: Antibacterial, potentially toxic, used to treat certain skin diseases. | pyridines; substituted aniline; sulfonamide; sulfonamide antibiotic | antiinfective agent; dermatologic drug; drug allergen; environmental contaminant; xenobiotic |
sulfasalazine | sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position. Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) | ||
cysteine | cysteine; cysteine zwitterion; L-alpha-amino acid; proteinogenic amino acid; serine family amino acid | EC 4.3.1.3 (histidine ammonia-lyase) inhibitor; flour treatment agent; human metabolite | |
quisqualic acid | Quisqualic Acid: An agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis. | non-proteinogenic alpha-amino acid | |
serine o-sulfate | L-serine O-sulfate : A non-proteinogenic L-alpha-amino acid that is the O-sulfo derivative of L-serine. serine O-sulfate: RN given refers to (L)-isomer | L-serine derivative; non-proteinogenic L-alpha-amino acid; O-sulfoamino acid | |
homocysteic acid | homocysteic acid : A non-proteinogenic alpha-amino acid that is homocysteine in which the thiol group has benn oxidised to the corresponding sulfonic acid. homocysteic acid: promotes growth in hypophysectomized rats; RN given refers to parent cpd L-homocysteic acid : A homocysteic acid with L-configuration. | homocysteic acid | NMDA receptor agonist |
susalimod | susalimod: analogue of sulphasalazine, was designed for use in the treatment of rheumatoid arthritis | ||
erastin | erastin : A member of the class of quinazolines that is quinazolin-4(3H)-one in which the hydrogens at positions 2 and 3 are replaced by 1-{4-[(4-chlorophenoxy)acetyl]piperazin-1-yl}ethyl and 2-ethoxyphenyl groups, respectively. It is an inhibitor of voltage-dependent anion-selective channels (VDAC2 and VDAC3) and a potent ferroptosis inducer. erastin: an antineoplastic agent; structure in first source | aromatic ether; diether; monochlorobenzenes; N-acylpiperazine; N-alkylpiperazine; quinazolines; tertiary carboxamide | antineoplastic agent; ferroptosis inducer; voltage-dependent anion channel inhibitor |